These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM). Thepot S; Itzykson R; Seegers V; Raffoux E; Quesnel B; Chait Y; Sorin L; Dreyfus F; Cluzeau T; Delaunay J; Sanhes L; Eclache V; Dartigeas C; Turlure P; Harel S; Salanoubat C; Kiladjian JJ; Fenaux P; Adès L; Blood; 2010 Nov; 116(19):3735-42. PubMed ID: 20664061 [TBL] [Abstract][Full Text] [Related]
6. Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work? Kundranda MN; Tibes R; Mesa RA Curr Hematol Malig Rep; 2012 Mar; 7(1):78-86. PubMed ID: 22170483 [TBL] [Abstract][Full Text] [Related]
7. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options. Iurlo A; Cattaneo D; Gianelli U Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941 [TBL] [Abstract][Full Text] [Related]
8. Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms. Czader M; Orazi A Am J Clin Pathol; 2015 Aug; 144(2):188-206. PubMed ID: 26185305 [TBL] [Abstract][Full Text] [Related]
9. Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms. Abruzzese E; Niscola P Expert Rev Hematol; 2020 Dec; 13(12):1349-1359. PubMed ID: 33226274 [No Abstract] [Full Text] [Related]
10. Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations. Li B; Mascarenhas JO; Rampal RK Curr Hematol Malig Rep; 2018 Dec; 13(6):588-595. PubMed ID: 30353413 [TBL] [Abstract][Full Text] [Related]
11. Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome. Yogarajah M; Tefferi A Mayo Clin Proc; 2017 Jul; 92(7):1118-1128. PubMed ID: 28688466 [TBL] [Abstract][Full Text] [Related]
12. A Concise Update on Risk Factors, Therapy, and Outcome of Leukemic Transformation of Myeloproliferative Neoplasms. Mascarenhas J Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S124-9. PubMed ID: 27521308 [TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical characteristics of bone marrow proliferative tumor progression to acute myeloid leukemia. Li Y; Zhang XY; Han J; Wang L Cancer Biomark; 2018; 23(4):469-472. PubMed ID: 30452397 [TBL] [Abstract][Full Text] [Related]
15. Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated? Björkholm M; Hultcrantz M; Derolf ÅR Best Pract Res Clin Haematol; 2014 Jun; 27(2):141-53. PubMed ID: 25189725 [TBL] [Abstract][Full Text] [Related]
16. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Nationwide Survey by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Takagi S; Masuoka K; Uchida N; Kurokawa M; Nakamae H; Imada K; Iwato K; Ichinohe T; Atsuta Y; Takami A; Yano S Biol Blood Marrow Transplant; 2016 Dec; 22(12):2208-2213. PubMed ID: 27667010 [TBL] [Abstract][Full Text] [Related]
18. How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms. Odenike O Blood; 2018 Nov; 132(22):2339-2350. PubMed ID: 30333119 [TBL] [Abstract][Full Text] [Related]
19. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms. Hu Z; Medeiros LJ; Wang W; Chen Z; Tang G; Hodjat P; Yang S; Fang L; Li Y; Verstovsek S; Hu S Mod Pathol; 2017 Jul; 30(7):940-951. PubMed ID: 28338652 [TBL] [Abstract][Full Text] [Related]